epirubicin has been researched along with Carcinoma, Intraepithelial in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amarillo, I; Fisher, SI; Rashidi, A | 1 |
| Hayashida, T; Ikeda, T; Jinno, H; Kitagawa, Y; Mukai, M; Sakata, M; Takahashi, M | 1 |
| Hadjileontis, CG; Kaloutsi, VD; Kostopoulos, IS; Kotoula, VA; Nikolaou, AC; Papadimitriou, CS | 1 |
| Brausi, M; Carpentier, P; de Reijke, TM; Hall, RR; Kurth, KH; Landsoght, KE; Sylvester, RJ; van de Beek, K | 1 |
| Esfahani, F; Mehraban, D | 1 |
| Arai, Y; Kanba, T; Shichiri, Y; Yoshida, S | 1 |
| Gertenbach, U; Hohenfellner, R; Huber, C; Meyenburg, W; Stöckle, M; Thüroff, JW; Voges, G; Wellek, S | 1 |
| Chionis, HS; Dauaher, HH; Melekos, MD; Paranychianakis, GS | 1 |
| Corselli, G; Ingargiola, GB; Pavone, C; Pavone-Macaluso, M; Serretta, V; Tripi, M | 1 |
| Duque, JL; Loughlin, KR | 1 |
| Bono, AV; Lovisolo, JA; Saredi, G | 1 |
| Koshikawa, T; Nakashima, N; Ohshima, S; Schenck, U; Takashi, M | 1 |
| Burcombe, RJ; Emmott, J; Lowe, J; Makris, A; Pittam, M; Wong, WL | 1 |
| Bogdanowicz, JF; Carpentier, PJ; Kurth, K; ten Kate, F; Van Reyswoud, I; Vijgh, WJ | 1 |
| Chisholm, GD; Hargreave, TB; James, K; Prescott, S; Smyth, JF | 1 |
| Blom, J; Carpentier, PJ; Groen, JM; Krueger, CG; Kurth, KH; Mross, K; ten Kate, F; van Aubel, O; van Caubergh, RD; Weissglas, G | 1 |
| da Silva, FC | 1 |
| Burk, K; Kurth, KH; Newling, D | 1 |
3 review(s) available for epirubicin and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicin.
Topics: Administration, Intravesical; Carcinoma in Situ; Doxorubicin; Epirubicin; Humans; Male; Urinary Bladder Neoplasms | 1993 |
An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Epirubicin; Ethoglucid; Humans; Immunotherapy; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 2000 |
The role of adriamycin and epirubicin in superficial bladder cancer and carcinoma in situ.
Topics: Carcinoma in Situ; Carcinoma, Papillary; Carcinoma, Transitional Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Europe; Female; Humans; Male; Multicenter Studies as Topic; Urinary Bladder Neoplasms | 1989 |
8 trial(s) available for epirubicin and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma in Situ; Combined Modality Therapy; Cyclophosphamide; Deoxycytidine; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Period; Taxoids; Treatment Outcome | 2010 |
Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma in Situ; Disease Progression; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Survival Rate; Time Factors; Urinary Bladder Neoplasms | 2005 |
[Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ].
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Cystitis; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Hemorrhage; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms | 1995 |
[The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Epirubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer.
Topics: Administration, Intravesical; Aged; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystitis; Epirubicin; Female; Follow-Up Studies; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Remission Induction; Urinary Bladder Neoplasms | 1993 |
Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer.
Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms | 2000 |
Cytological changes induced by intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma in Situ; Case-Control Studies; Epirubicin; Female; Humans; Male; Middle Aged; Urinary Bladder; Urinary Bladder Neoplasms | 2000 |
The role of adriamycin and epirubicin in superficial bladder cancer and carcinoma in situ.
Topics: Carcinoma in Situ; Carcinoma, Papillary; Carcinoma, Transitional Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Europe; Female; Humans; Male; Multicenter Studies as Topic; Urinary Bladder Neoplasms | 1989 |
8 other study(ies) available for epirubicin and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
BRCA2-associated therapy-related acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Genes, BRCA2; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Taxoids | 2015 |
An extremely rare case of synchronous occurrence in the larynx of intravascular lymphoma and in situ squamous cell carcinoma.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cyclophosphamide; Epirubicin; Humans; Immunohistochemistry; Laryngeal Neoplasms; Lymphoma; Male; Middle Aged; Prednisone; Time Factors; Treatment Outcome; Vascular Neoplasms; Vincristine | 2003 |
Re: Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer-Genito-Urinary Group Phase III Trial (30906).
Topics: Adjuvants, Immunologic; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma in Situ; Clinical Trials, Phase III as Topic; Epirubicin; Humans; Mathematical Computing; Multicenter Studies as Topic; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Reproducibility of Results; Sample Size; Urinary Bladder Neoplasms | 2005 |
Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Phase 1/2 study of intravesical epirubicin in patients with carcinoma in situ of the bladder.
Topics: Administration, Intravesical; Carcinoma in Situ; Drug Evaluation; Epirubicin; Humans; Neoplasm Recurrence, Local; Survival Rate; Urinary Bladder Neoplasms | 1991 |
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Epirubicin; Humans; Interferon-gamma; Mitomycin; Mitomycins; Radioimmunoassay; Urinary Bladder Neoplasms | 1990 |
Phase I/II study of intravesical epirubicin in patients with carcinoma in situ of the bladder.
Topics: Administration, Intravesical; Biopsy; Carcinoma in Situ; Combined Modality Therapy; Drug Evaluation; Epirubicin; Humans; Urinary Bladder Neoplasms | 1990 |
Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer.
Topics: Administration, Intravesical; Carcinoma in Situ; Carcinoma, Papillary; Combined Modality Therapy; Epirubicin; Humans; Instillation, Drug; Neoplasm Recurrence, Local; Prognosis; Urinary Bladder; Urinary Bladder Neoplasms | 1989 |